主题：【原创】吃胖快还是动胖快？可能性之探讨。想减体重者也可参考 -- 铁手

Rimonabant is a selective CB1 endocannabinoid receptor antagonist indicated for the treatment of obesity.

It works by blocking endogenous cannabinoid binding to neuronal CB1 receptors. Activation of these receptors by endoegenous cannabinoids, such as anadamide, increases appetite. It is the only endocannabinoid receptor antagonist in clinical development and thus offers a unique therapeutic approach to appetite control and weight reduction.

正在等FDA批。烦这个，恕不翻译了。